Finanzwire Finanzwire
Basculer en Français
10938 Companies
238839 Keywords
167680 Articles
128375 Press releases
Headlines Articles Press releases Americord Remove
  1. Home
  2. Companies
  3. Americord
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/23/2024 at 16:30, 2 years 6 months ago

    Americord makes breakthrough in treating Motor Neuron Disease with cord blood stem cells

    Americord Stem Cells Cord Blood Motor Neuron Disease Treatment
  • PRESS RELEASE

    published on 02/23/2024 at 16:30, 2 years 6 months ago

    Americord Releases Cord Blood Stem Cells for Treatment of Motor Neuron Disease

    Americord releases cord blood stem cells for the treatment of motor neuron disease in India, highlighting the therapeutic potential of stem cells in healthcare
    Healthcare Americord Motor Neuron Disease Treatment Cord Blood Stem Cells
    Logo of Americord
  • PRESS RELEASE

    published on 12/06/2023 at 15:00, 2 years 8 months ago

    Americord Elevates Standards With Strategic Lab Relocation to Somerset, New Jersey

    Americord, a leader in the biobanking industry, has relocated its laboratory from New York City to a state-of-the-art facility in Somerset, New Jersey, marking a milestone in advancing research, product quality, and growth opportunities
    Americord Biobanking Laboratory Relocation Research Somerset New Jersey
    Logo of Americord
Accesswire
  • Published on 09/05/2026 at 04:05, 1 day 3 hours ago

    Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update

  • Published on 09/04/2026 at 23:30, 1 day 7 hours ago

    FutureGen Industries Announces Shares for Debt Settlement

  • Published on 09/04/2026 at 23:00, 1 day 8 hours ago

    Golden Minerals Announces Management Change and Argentine Project Update

  • Published on 09/04/2026 at 22:30, 1 day 8 hours ago

    Panther Minerals Closes Brokered Private Placement of $3,000,000

  • Published on 09/04/2026 at 14:30, 1 day 16 hours ago

    Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

View all ACCESSWIRE
EQS Group
  • Published on 09/06/2026 at 06:00, 1 hour 28 minutes ago

    CoolFly to Showcase Personal Flight Portfolio and NA80 Flight-Control Technology at IFA Berlin 2026

  • Published on 09/06/2026 at 05:15, 2 hours 14 minutes ago

    Experience AI Companion in Everyday Life at Hisense IFA 2026

  • Published on 09/05/2026 at 22:20, 9 hours 9 minutes ago

    PITAKA Marks Its Next Chapter in Berlin With "Signals in the Wind," Unveiling New iPhone 18 Accessories

  • Published on 09/05/2026 at 19:35, 11 hours 54 minutes ago

    ToolDance Unveils X1 Smart Desktop CNC Mill at IFA 2026

  • Published on 09/05/2026 at 14:00, 17 hours 29 minutes ago

    Global investment boom could create USD 200 billion commercial insurance opportunity amid rising accumulation risks, finds Swiss Re Institute

View all EQS
Les Echos
  • Published on 09/04/2026 at 18:57, 1 day 12 hours ago

    Disclosure of transactions in own shares from September 1 to September 4, 2026

  • Published on 09/04/2026 at 17:45, 1 day 13 hours ago

    Declaration of voting rights at the end of August 2026

  • Published on 09/04/2026 at 17:45, 1 day 13 hours ago

    DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 09/04/2026 at 16:00, 1 day 15 hours ago

    Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026

  • Published on 09/04/2026 at 16:00, 1 day 15 hours ago

    Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy